Takatomo Ogahara

Title: Takatomo Ogahara: Innovator in Cholecystokinin Antagonists

Introduction

Takatomo Ogahara is a prominent inventor based in Minoo, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of cholecystokinin antagonists. With a total of 7 patents to his name, Ogahara's work has had a notable impact on medical science.

Latest Patents

Among his latest patents, Ogahara has developed tricyclic compounds that exhibit cholecystokinin antagonist activity. One of his inventions relates to novel cholecystokinin antagonists characterized by a specific formula, where R¹ is aryl or substituted aryl, along with a pharmaceutically acceptable salt. Another patent focuses on a compound where R¹ is aryl, which may have suitable substituents, and includes various structural components that enhance its efficacy as a cholecystokinin antagonist.

Career Highlights

Takatomo Ogahara is currently associated with Fujisawa Pharmaceutical Company, Ltd., where he continues to innovate and contribute to pharmaceutical research. His work has been instrumental in advancing the understanding and application of cholecystokinin antagonists in medical treatments.

Collaborations

Ogahara has collaborated with notable coworkers, including Yoshinari Sato and Teruaki Matuo, to further enhance the research and development of pharmaceutical compounds.

Conclusion

Takatomo Ogahara's contributions to the field of pharmaceuticals, particularly through his patents on cholecystokinin antagonists, highlight his role as an influential inventor. His ongoing work at Fujisawa Pharmaceutical Company, Ltd. continues to pave the way for advancements in medical science.